4 results
To determine the safety and efficacy of coversin in the treatment of patients with PNH resistant to eculizumab.
To compare the efficacy and safety of lenalidomide versus placebo maintenance therapy (standard care).
* The purpose of this study is to to determine the safety profile of long-termCoversin treatment.* To observe the long term safety and efficacy of Coversin over periods in excess of 6 months* To assess the long term patient acceptability of Coversin…
Primary Objective to show that PPIs compared to placebo are an effective treatment of secondary hemochromatosis in a relative large number of patients with hereditary anemia and mild iron overload. Secondary Objectives: To assess the safety and side…